Explore
← New search
2 matching publication(s)
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.
PMID 36450752 · Nat Commun · 2022
L1
70/100
Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma.
PMID 33634984 · Clin Transl Med · 2021
L1
85/100